SCHEMBL5525632

SCHEMBL5525632

CC(C)(C)NC(=O)c1cc(-c2ccc(CNS(C)(=O)=O)cn2)n(-c2ccccc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1G O43497 3/20 0.44
CACNA1H O95180 3/20 0.44
CNR1 P21554 2/20 0.42
CNR2 P34972 2/20 0.42
MALT1 Q9UDY8 3/20 0.41
RIPK1 Q13546 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.38
RPA1 P27694 2/20 0.38
BCL2 P10415 1/20 0.36
MDM2 Q00987 1/20 0.36
MCL1 Q07820 1/20 0.36
MAPK14 Q16539 1/20 0.36
NTRK1 P04629 1/20 0.36
MAPK9 P45984 1/20 0.36
DHODH Q02127 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5526762 0.91 CNR1 (0.47) CACNA1GCACNA1HCNR1CNR2MALT1
SCHEMBL5522953 0.88 CACNA1G (0.51) CACNA1GCACNA1HCNR1CNR2MALT1
SCHEMBL5518176 0.85 CNR1 (0.46) CACNA1GCACNA1HCNR1CNR2MALT1
SCHEMBL14416562 0.83 CACNA1G (0.48) CACNA1GCACNA1HCNR1CNR2MALT1
SCHEMBL5532114 0.81 CACNA1G (0.45) CACNA1GCACNA1HCNR1CNR2MEN1
SCHEMBL5531655 0.80 CACNA1G (0.43) CACNA1GCACNA1HCNR1CNR2NTRK1
SCHEMBL5525413 0.80 CNR1 (0.48) CACNA1GCACNA1HCNR1CNR2KMT2A
SCHEMBL5526193 0.80 CNR1 (0.50) CACNA1GCACNA1HCNR1CNR2KMT2A
SCHEMBL5526243 0.79 CNR1 (0.49) CACNA1GCACNA1HCNR1CNR2MALT1
SCHEMBL5527685 0.79 CNR1 (0.44) CACNA1GCACNA1HCNR1CNR2MALT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
EP-1698626-A1 AMIDOPYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219210-A1 Amidopyrazole Derivative PTGER1, PTGS1, PTGER2 CACNA1G 3126/4885CACNA1H 3319/4885CNR1 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.